Presented by Ziva Abraham, Founder & CEO of Microrite and Danielle DeCesaro, RMB Sr. Associate Product Manager
Rapid Micro Biosystems® partnered with American Pharmaceutical Review to host this webinar bringing together industry subject matter experts, Ziva Abraham and Danielle DeCesaro, to share their knowledge on how automated microbial detection methods, such as the Growth Direct® System, provide the rapid results needed when mold contamination presents.
COMPLETE THE FORM TO VIEW THE WEBINAR
Overview
Quick to spread and difficult to detect, molds can compromise a facility in the time it takes to confirm their presence. RMBNucleus™ Mold Alarm allows investigations to begin in as little as one day with automated alerts triggered by detection of molds during the early stages of incubation.
After rapid detection, accurate identification is critical in performing root cause analysis, effective disinfectant protocols, and confidently remediating the source of mold contamination. Maintaining quality control of the manufacturing environment also requires a solid understanding of objectionable organisms and their pathogenicity, all critically necessary in ensuring patient safety.
In this webinar you'll learn:
Who should attend: